Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | TRDAEntrada Therapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $25.42M |
| Revenue, yoy | −87.9% |
| Net income | $143.75M |
| Net income, yoy | −319.0% |
| Net margin | -565.5% |
| Free cash flow | $129.55M |
| FCF margin | -509.6% |
| EPS, diluted | $3.47 |
Add another company.